(Q45858394)

17 December 2017

title

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia (English)

1 reference

17 December 2017

1 reference

H Shigematsu

1

1 reference

17 December 2017

K Yasuda

2

1 reference

17 December 2017

T Iwai

3

1 reference

17 December 2017

T Sasajima

4

1 reference

17 December 2017

S Ishimaru

5

1 reference

17 December 2017

Y Ohashi

6

1 reference

17 December 2017

T Yamaguchi

7

1 reference

17 December 2017

T Ogihara

8

1 reference

17 December 2017

R Morishita

9

1 reference

17 December 2017

publication date

15 April 2010

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

17

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

1152-1161

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2010.51

exact match

0 references

cites work

Roles of P2-purinoceptors in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Presidential address: a team for the 21st century: the vascular center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

7 January 2021

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

7 January 2021

Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

7 January 2021

Images in Cardiovascular Medicine: Percutaneous myocardial gene transfer of phVEGF-2

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

7 January 2021

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

7 January 2021

Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.51

7 January 2021

Identifiers

DOI

10.1038/GT.2010.51

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017